KPPA Consulting

EU Legislative Interests

EU Draft Regulation on Substances of Human Origin, EU Pharmaceutical Legislation revision, with EU Orphan Drug legislation, Cross border healthcare - R&D - HTA - biotech related EU files, EU Critical Medicines legislation/Act, EU Biotech Act

Communication Activities

As to -inter alia- the implementation process related to the EU Draft Regulation on substances of human origin, the ongoing revision process of the EU Pharmaceutical legislation package, Critical Medicines related EU legislation/Act, and all related advocacy activities carried out in the clients' interest with the objective to influence the decision-making processes of the Union institutions, to cover amongst others: (a) preparation of position papers and amendments related such as to the ongoing EU SoHo Draft Regulation process, as well as planned position papers and amendments on the EU Pharma legislation revision package process, also drafting and sending of other info material, open letters, and carrying out related research; (b) organisation of or participation in EU institutions' policymaker outreach meetings (with members of EU Parliament, Council of EU/EU Presidencies reps/EU Perm Reps, EU Commission), or in EU institutional conferences or EU policies events supported by clients, and use/forward existing clients' position papers and proposed amendments on respective EU policies and legislations, (c) planned contribution or participation in EU policies/legislations consultations, hearings or other initiatives (e.g. EU Health Summit, EU Stakeholder Platform, EU Critical Medicines Alliance, etc).

Interests Represented

Advances interests of their clients